Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 25009298)

1.

Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis.

Liu Z, Zhang J, Gao Y, Pei L, Zhou J, Gu L, Zhang L, Zhu B, Hattori N, Ji J, Yuasa Y, Kim W, Ushijima T, Shi H, Deng D.

Clin Cancer Res. 2014 Sep 1;20(17):4598-612. doi: 10.1158/1078-0432.CCR-13-3380. Epub 2014 Jul 9.

PMID:
25009298
2.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

3.

Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas.

Okada T, Nakamura M, Nishikawa J, Sakai K, Zhang Y, Saito M, Morishige A, Oga A, Sasaki K, Suehiro Y, Hinoda Y, Sakaida I.

Cancer Sci. 2013 Oct;104(10):1309-14. doi: 10.1111/cas.12228. Epub 2013 Aug 9.

PMID:
23829175
4.

CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.

Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M.

Clin Cancer Res. 2006 May 15;12(10):2995-3002.

5.

High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer.

Chen HY, Zhu BH, Zhang CH, Yang DJ, Peng JJ, Chen JH, Liu FK, He YL.

Cancer Sci. 2012 Jan;103(1):73-9. doi: 10.1111/j.1349-7006.2011.02129.x. Epub 2011 Nov 24.

PMID:
22017425
6.

Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma.

Jee CD, Kim MA, Jung EJ, Kim J, Kim WH.

Eur J Cancer. 2009 May;45(7):1282-93. doi: 10.1016/j.ejca.2008.12.027. Epub 2009 Feb 3.

PMID:
19195878
7.

Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.

Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Ito Y, Chayama K, Yasui W.

Pathobiology. 2004;71(3):137-43.

PMID:
15051926
8.

Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.

Tanaka T, Nakamura J, Kitajima Y, Kai K, Miyake S, Hiraki M, Ide T, Koga Y, Noshiro H.

Int J Oncol. 2013 Mar;42(3):894-902. doi: 10.3892/ijo.2013.1759. Epub 2013 Jan 3.

PMID:
23291975
9.

CpG methylation of transcription factor 4 in gastric carcinoma.

Joo JK, Kim SH, Kim HG, Kim DY, Ryu SY, Lee KH, Lee JH.

Ann Surg Oncol. 2010 Dec;17(12):3344-53. doi: 10.1245/s10434-010-1131-z. Epub 2010 Jun 29.

PMID:
20585880
10.

Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.

Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, Hosokawa M, Shinomura Y, Imai K, Tokino T.

Cancer. 2006 Apr 1;106(7):1467-79.

11.

Promoter methylation and expression of TIMP3 gene in gastric cancer.

Guan Z, Zhang J, Song S, Dai D.

Diagn Pathol. 2013 Jul 2;8:110. doi: 10.1186/1746-1596-8-110.

12.

Methylation status of individual CpG sites within Alu elements in the human genome and Alu hypomethylation in gastric carcinomas.

Xiang S, Liu Z, Zhang B, Zhou J, Zhu BD, Ji J, Deng D.

BMC Cancer. 2010 Feb 17;10:44. doi: 10.1186/1471-2407-10-44.

13.

Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas.

Deng DJ, Zhou J, Zhu BD, Ji JF, Harper JC, Powell SM.

World J Gastroenterol. 2003 Jan;9(1):26-9.

14.

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma.

Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ, Kang GH.

Lab Invest. 2004 Apr;84(4):479-84.

15.

Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma.

Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Chayama K, Yasui W.

Int J Cancer. 2004 Jun 10;110(2):212-8.

PMID:
15069684
16.

Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo.

Du Y, Liu Z, Gu L, Zhou J, Zhu BD, Ji J, Deng D.

BMC Cancer. 2012 Jun 15;12:249. doi: 10.1186/1471-2407-12-249.

17.

Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.

Leung WK, Yu J, Bai AH, Chan MW, Chan KK, To KF, Chan FK, Ng EK, Chung SC, Sung JJ.

Mol Carcinog. 2003 Jun;37(2):91-7.

PMID:
12766908
18.

[CpG island methylation of E-cadherin gene promoter in gastric carcinoma].

Zhou YN, Xu CP, Han B, Ji R.

Ai Zheng. 2005 Oct;24(10):1220-4. Chinese.

PMID:
16219136
19.

Promoter methylation of cyclin D2 gene in gastric carcinoma.

Oshimo Y, Nakayama H, Ito R, Kitadai Y, Yoshida K, Chayama K, Yasui W.

Int J Oncol. 2003 Dec;23(6):1663-70.

PMID:
14612939
20.

Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.

Deng J, Liang H, Ying G, Dong Q, Zhang L, Yu J, Fan D, Hao X.

J Am Coll Surg. 2014 Nov;219(5):904-13. doi: 10.1016/j.jamcollsurg.2014.06.014. Epub 2014 Jun 26.

PMID:
25260683
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk